Investor Outlook: Apotex begins next chapter after landmark TSX debut
Jeff Watson, president and CEO of Apotex, joins BNN Bloomberg to discuss the company's next chapter and the pharma landscape in Canada. Apotex is entering a new phase as a public company after completing a $1.3-billion IPO and debuting on the Toronto …